Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant.

ABSTRACT:

SUBMITTER: Tai W 

PROVIDER: S-EPMC9157036 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature